Tarsus Pharmaceuticals Inc — Quarterly Financial Statistics (NASDAQ:TARS) | MetaTrader

Open full chart

Financials

Overview Finanzbericht Statistics Dividends

Quarterly Annual

Cash from operating activities 8.65 M22.18 M20.65 M29.39 M-18.26 M-19.33 M 12.45 M Cash from investing activities -3.13 M59.57 M34.94 M51.7 M4.74 M-49.27 M 42.12 M Cash from financing activities 639 K2.93 M136.56 M1.95 M2.56 M2.31 M 143.39 M Free cash flow 8.37 M22.11 M20.06 M28.39 M-20.17 M-25.69 M 2.59 M

Nachrichten

Miners Barrick, Pan American Leads 10 Hot Growth Stocks Onto The IBD 50, Other Premium Lists

These Growth Stocks Form Classic Cup Bases. Here's Where To Buy.

ASML, With Unique AI Tech, Leads 8 Hot Growth Stocks Joining IBD's Top Screens

Construction Star Leads 11 Hot Stocks To Various Best Growth Lists like IBD 50, Sector Leaders

AMD, IBM among market cap stock movers on Tuesday

Tarsus: EPS verfehlt Schätzungen um 0,12 $ - Umsatz besser als erwartet

Tarsus earnings missed by $0.12, revenue topped estimates

Tarsus Pharmaceuticals, Inc. 2025 Q4 - Results - Earnings Call Presentation (NASDAQ:TARS) 2026-02-23

Tarsus Pharmaceuticals, Inc. (TARS) Reports Q4 Loss, Beats Revenue Estimates

Earnings Call Transkript: Tarsus Pharmaceuticals verzeichnet starkes Wachstum in Q4 2025

Earnings call transcript: Tarsus Pharmaceuticals Q4 2025 sees robust growth

Tarsus vor Bewährungsprobe: Anleger blicken auf Umsatzdynamik und Profitabilität